Form 8-K

8-K — AGILENT TECHNOLOGIES, INC.

Accession: 0001090872-26-000062

Filed: 2026-08-26

Period: 2026-08-26

CIK: 0001090872

SIC: 3826 (LABORATORY ANALYTICAL INSTRUMENTS)

Item: Results of Operations and Financial Condition

Item: Financial Statements and Exhibits

Documents

8-K — a-20260826.htm (Primary)

EX-99.1 (exhibit991-q326pressrelease.htm)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K

8-K (Primary)

Filename: a-20260826.htm · Sequence: 1

a-20260826

0001090872false00010908722026-08-262026-08-26

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 26, 2026

AGILENT TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

Delaware 001-15405 77-0518772

(State or other jurisdiction (Commission (IRS Employer

of incorporation) File Number) Identification No.)

5301 Stevens Creek Boulevard, Santa Clara, CA 95051

(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code (800) 227-9770

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

TITLE OF EACH CLASS TRADING SYMBOL(S) NAME OF EACH EXCHANGE ON WHICH REGISTERED

COMMON STOCK, $0.01 PAR VALUE A New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02. Results of Operations and Financial Condition.

On August 26, 2026, Agilent Technologies, Inc. (the “Company”) issued its press release announcing financial results for the third fiscal quarter ended July 31, 2026. A copy of this press release is attached as Exhibit 99.1.

The information in this Item 2.02 of Form 8-K and Exhibit 99.1 attached hereto is furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended.

The Company provides non-GAAP financial information in order to provide meaningful supplemental information regarding its operational performance and to enhance its investors’ overall understanding of its core current financial performance and its prospects for the future. The Company believes that its investors benefit from seeing its results “through the eyes” of management in addition to the GAAP presentation. Management measures segment and enterprise performance using measures such as those that are disclosed in the press release attached as Exhibit 99.1. This information facilitates management’s internal comparisons to the Company’s historical operating results and comparisons to competitors’ operating results. Non-GAAP financial information allows for greater transparency to supplemental information used by management in its financial and operations decision making. Historically, the Company has reported similar non-GAAP financial information to its investors and believes that the inclusion of comparative numbers provides consistency in its financial reporting.

This non-GAAP financial information is not in accordance with, or an alternative for, generally accepted accounting principles in the United States. It excludes items, such as restructuring and amortization, that may have a material effect on the Company’s expenses and earnings per share calculated in accordance with GAAP. Management monitors these items to ensure that expenses are in line with expectations and that the Company's GAAP results are correctly stated but does not use them to measure the ongoing operating performance of the Company. The non-GAAP financial information the Company provides may be different from the non-GAAP financial information provided by other companies.

Additional explanation of non-GAAP financial information is provided in Exhibit 99.1.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit No. Description

99.1

Press release announcing financial results for the third fiscal quarter ended July 31, 2026

104 Cover page interactive data file (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

AGILENT TECHNOLOGIES, INC.

By: /s/ Michael Buckner

Name: Michael Buckner

Title: Senior Vice President, Chief Legal Officer and Secretary

Date: August 26, 2026

EX-99.1

Filename: exhibit991-q326pressrelease.htm · Sequence: 2

Document

Exhibit 99.1

Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results

Delivers strong Q3 results and raises FY26 revenue growth, margin expansion, and non-GAAP EPS(4) guidance on continued operational momentum

Third-quarter fiscal year 2026

•Revenue of $1.88 billion for the third quarter ended July 31, 2026, representing growth of 8.1% reported and up 7.3% core(1) compared with the third quarter of fiscal year 2025.

•GAAP operating margin of 23.6%, expanded by 290 basis points year-over-year and 190 basis points sequentially.

•Non-GAAP operating margin(2) of 28.3% (including an approximately 110 basis point net benefit from tariff refunds), expanded by 320 basis points year-over-year and 190 basis points sequentially.

•GAAP net income of $362 million; earnings per share (EPS) of $1.28, an increase of 8% from the third quarter of fiscal year 2025.

•Non-GAAP net income(3) of $459 million (including a $17 million net benefit from tariff refunds); non-GAAP EPS(3) of $1.62 (including a $0.06 net benefit from tariff refunds), an increase of 18% from the third quarter of fiscal year 2025.

Fiscal year 2026 improved outlook and fourth-quarter guidance

•Fiscal year 2026 revenue is now expected in the range of $7.49 billion to $7.51 billion, representing a range of up 7.8% to 8.1% reported and up 5.8% to 6.0% core,(1)(5) an increase of 65 basis points at the midpoint.

•Non-GAAP fiscal year 2026 operating margin expansion(2) at the midpoint of core revenue growth guidance is now expected to be over 130 basis points (including approximately 30 basis points in net benefit from tariff refunds in the third quarter).

•Non-GAAP fiscal year 2026 EPS(4) is now expected in the range of $6.18 to $6.21, an increase of 15 cents at the midpoint (including $0.06 net benefit from tariff refunds in the third quarter) versus our prior guide.

•Fourth-quarter 2026 revenue is expected in the range of $1.98 billion to $2.0 billion, growth of 6.4% to 7.4% reported and up 5.2% to 6.2% core(1)(5). Non-GAAP EPS(4) is expected in the range of $1.71 to $1.74 per share. This guidance does not include any future benefit from tariff refunds.

SANTA CLARA, California, August 26, 2026 — Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.88 billion for the third quarter ended July 31, 2026, representing growth of 8.1% reported and up 7.3% core(1) compared with the third quarter of fiscal year 2025.

Third-quarter GAAP net income was $362 million, or $1.28 per share. This compares with $336 million, or $1.18 per share, in the third quarter of fiscal year 2025. Non-GAAP net income(3) was $459 million (including a $17 million net benefit from tariff refunds), or $1.62 per share (including a $0.06 net benefit from tariff refunds), during the quarter, compared with $390 million, or $1.37 per share, during the year-ago quarter.

“Agilent’s exceptional third-quarter performance reflects the sustained momentum created by our strategy, our execution discipline, and the compounding impact of the Ignite Operating System,” said Agilent CEO Padraig McDonnell. “We are seeing improving end markets, stronger demand in key regions, and excellent customer response to our innovative product launches. All of this gives us confidence in our increased outlook and our ability to sustainably outperform our end markets.”

Financial Highlights

Life Sciences and Diagnostics Markets Group

The Life Sciences and Diagnostics Markets Group (LDG) reported third-quarter revenue of $746 million, growth of 11% reported and 10% core(1) year-over-year. LDG’s operating margin for the quarter was 23.5%.

Agilent CrossLab Group

The Agilent CrossLab Group (ACG) reported third-quarter revenue of $786 million, growth of 6% reported and 5% core(1) year-over-year. ACG’s operating margin for the quarter was 34.3%.

Applied Markets Group

The Applied Markets Group (AMG) reported third-quarter revenue of $346 million, growth of 7% reported and 7% core(1) year-over-year. AMG’s operating margin for the quarter was 24.9%.

Conference Call

Agilent’s management will present additional details regarding the company’s third-quarter 2026 financial results on a conference call with investors today at 1:30 p.m. PT. This event will be broadcast live online in listen-only mode. To listen to the webcast, select the “Q3 2026 Agilent Technologies, Inc. Earnings Conference Call” link on the Agilent Investor Relations website. The replay of the call will remain on the company website for 90 days.

About Agilent Technologies

Agilent Technologies, Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.95 billion in fiscal year 2025 and employs approximately 18,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn and Facebook.

Forward-Looking Statements

This news release contains forward-looking statements as defined in the Securities Exchange Act of 1934 and is subject to the safe harbors created therein. The forward-looking statements contained herein include, but are not limited to, information regarding Agilent’s growth prospects, business, financial results, revenue, non-GAAP earnings guidance for fiscal year and fourth-quarter 2026, and the effects of its operational transformation and customer and market-focused strategy. These forward-looking statements involve risks and uncertainties that could cause Agilent’s results to differ materially from management’s current expectations. Such risks and uncertainties include, but are not limited to, unforeseen changes in the strength of Agilent’s customers’ businesses; unforeseen changes in the demand for current and new products, technologies, and services; unforeseen changes in the currency markets; customer purchasing decisions and timing; and the risk that Agilent is not able to realize the savings expected from integration and restructuring activities. In addition, other risks that Agilent faces in running its operations include the ability to execute successfully through business cycles; the ability to meet and achieve the benefits of its operational transformation, customer and market-focused strategy and cost-reduction goals and otherwise successfully adapt its cost structures to continuing changes in business conditions; ongoing competitive, pricing and gross-margin pressures; the risk that its cost-cutting initiatives will impair its ability to develop products and remain competitive and to operate effectively; the impact of geopolitical uncertainties and global economic conditions on its operations, its markets and its ability to conduct business; the ability to improve asset performance to adapt to changes in demand; the impact relating to or arising from changes

to tariffs, import/export or trade policies; the ability of its supply chain to adapt to changes in demand; the ability to successfully introduce new products at the right time, price and mix; the ability of Agilent to successfully integrate recent acquisitions; the ability of Agilent to successfully comply with certain complex regulations; and other risks detailed in Agilent’s filings with the Securities and Exchange Commission, including its quarterly report on Form 10-Q for the fiscal quarter ended April 30, 2026. Forward-looking statements are based on the beliefs and assumptions of Agilent’s management and on currently available information. Agilent undertakes no responsibility to publicly update or revise any forward-looking statement.

(1) Core or organic constant currency revenue growth excludes the impact of currency and acquisitions and divestitures within the past 12 months. Core or organic constant currency revenue is a non-GAAP measure. Reconciliations between GAAP revenue and core or organic constant currency revenue for third quarter 2026 are set forth on page 7 of the attached tables along with additional information regarding the use of this non-GAAP measure. Core or organic constant currency revenue growth rate as projected for fourth quarter 2026 and full fiscal year 2026 excludes the impact of currency and acquisitions and divestitures within the past 12 months. Most of the excluded amounts pertain to events that have not yet occurred and are not currently possible to estimate with a reasonable degree of accuracy and could differ materially. Therefore, no reconciliation to GAAP amounts has been provided for the projection.

(2) Non-GAAP operating margin excludes the impacts of restructuring and other related costs, intangibles amortization, transformation initiatives and acquisition and integration costs. A reconciliation between non-GAAP operating margin and GAAP operating margin is set forth on page 5 of the attached tables along with additional information regarding the use of this non-GAAP measure. Non-GAAP operating margin as projected for full fiscal year 2026 excludes primarily the impacts of restructuring and other related costs, intangible amortization, transformation initiatives and acquisition and integration costs. Most of these excluded amounts pertain to events that have not yet occurred and are not currently possible to estimate with a reasonable degree of accuracy and could differ materially. Therefore, no reconciliation to GAAP amounts has been provided.

(3) Non-GAAP net income and non-GAAP EPS exclude the impacts of restructuring and other related costs, intangibles amortization, transformational initiatives, acquisition and integration costs and net (gain) loss on equity securities. Agilent also excludes any tax benefits or expenses that are not directly related to ongoing operations, and which are either isolated or are not expected to occur again with any regularity or predictability. A reconciliation between non-GAAP net income and GAAP net income and a reconciliation between non-GAAP EPS and GAAP EPS is set forth on page 4 of the attached tables along with additional information regarding the use of this non-GAAP measure.

(4) Non-GAAP EPS as projected for fourth quarter 2026 and full fiscal year 2026 exclude primarily the estimated impacts of non-cash intangibles amortization, transformational initiatives, and acquisition and integration costs. Agilent also excludes any tax benefits or expenses that are not directly related to ongoing operations, and which are either isolated or are not expected to occur again with any regularity or predictability. Most of these excluded amounts pertain to events that have not yet occurred and are not currently possible to estimate with a reasonable degree of accuracy and could differ materially. Therefore, no reconciliation to GAAP amounts has been provided. Future amortization of intangibles is expected to be approximately $27 million per quarter.

(5) Core or organic constant currency revenue growth outlook is based on forecasted currency exchange rates.

# # #

INVESTOR CONTACT:

Tejas Savant

+1 917-574-4018

tejas.savant@agilent.com

Media Contact:

Andréa Topper

408-709-0060

andrea.topper@agilent.com

AGILENT TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In millions, except per share data)

(Unaudited)

PRELIMINARY

Three Months Ended Nine Months Ended

July 31, July 31,

2026 2025 2026 2025

Net revenue $ 1,878 $ 1,738 $ 5,511 $ 5,087

Costs and expenses:

Cost of products and services 836 850 2,533 2,434

Research and development 123 111 366 336

Selling, general and administrative 475 417 1,416 1,281

Total costs and expenses 1,434 1,378 4,315 4,051

Income from operations 444 360 1,196 1,036

Interest income 15 16 43 45

Interest expense (29) (28) (79) (85)

Other income (expense), net 14 18 56 (3)

Income before taxes 444 366 1,216 993

Provision for income taxes 82 30 210 124

Net income $ 362 $ 336 $ 1,006 $ 869

Net income per share:

Basic $ 1.28 $ 1.18 $ 3.55 $ 3.05

Diluted $ 1.28 $ 1.18 $ 3.55 $ 3.05

Weighted average shares used in computing net income per share:

Basic 282 284 283 285

Diluted 283 285 283 285

The preliminary income statement is estimated based on our current information.

AGILENT TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In millions, except par value and share data)

(Unaudited)

PRELIMINARY

July 31,

2026 October 31,

2025

ASSETS

Current assets:

Cash and cash equivalents $ 1,758 $ 1,789

Accounts receivable, net 1,478 1,487

Inventory 1,117 1,025

Other current assets 340 293

Total current assets 4,693 4,594

Property, plant and equipment, net 2,134 2,023

Goodwill 5,030 4,473

Other intangible assets, net 906 445

Long-term investments 130 133

Other assets 1,074 1,059

Total assets $ 13,967 $ 12,727

LIABILITIES AND EQUITY

Current liabilities:

Accounts payable $ 608 $ 570

Employee compensation and benefits 423 443

Deferred revenue 640 624

Short-term debt 304 304

Other accrued liabilities 314 406

Total current liabilities 2,289 2,347

Long-term debt 3,645 3,050

Retirement and post-retirement benefits 128 126

Other long-term liabilities 542 463

Total liabilities 6,604 5,986

Total Equity:

Stockholders' equity:

Preferred stock; $0.01 par value; 125,000,000 shares authorized; none issued and outstanding 3 — —

Common stock; $0.01 par value; 2,000,000,000 shares authorized; 281,965,813 shares at July 31, 2026 and 283,054,377 shares at October 31, 2025, issued and outstanding 3 3

Additional paid-in-capital 5,681 5,575

Retained earnings 1,912 1,389

Accumulated other comprehensive loss (233) (226)

Total stockholders' equity 7,363 6,741

Total liabilities and stockholders' equity $ 13,967 $ 12,727

The preliminary balance sheet is estimated based on our current information.

AGILENT TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In millions)

(Unaudited)

PRELIMINARY

Nine Months Ended

July 31, July 31,

2026 2025

Cash flows from operating activities:

Net income $ 1,006 $ 869

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization 200 217

Share-based compensation 105 102

Deferred taxes expense (benefit) 77 (35)

Excess and obsolete inventory related charges 35 30

Net (gain) loss on equity securities 2 28

Asset impairment charges — 15

Other non-cash (income) expense, net 12 4

Changes in assets and liabilities:

Accounts receivable, net 16 (44)

Inventory (110) (72)

Accounts payable 41 (13)

Employee compensation and benefits (25) (26)

Other assets and liabilities (295) (61)

Net cash provided by operating activities (a)

1,064 1,014

Cash flows from investing activities:

Payments to acquire property, plant and equipment (249) (314)

Proceeds from sale of equity securities — 5

Proceeds from convertible note — 2

Payments in exchange for convertible note (3) (1)

Payments to acquire businesses and intangible assets, net of cash acquired (950) 4

Net cash used in investing activities (1,202) (304)

Cash flows from financing activities:

Proceeds from issuance of common stock under employee stock plans 63 60

Payment of taxes related to net share settlement of equity awards (31) (28)

Payments for repurchase of common stock (295) (340)

Payment of excise taxes related to repurchases of common stock (3) (10)

Payments of dividends (216) (212)

Proceeds from issuance of long-term debt 600 4

Repayments of long-term debt (4) (2)

Payments of debt issuance costs (5) —

Net proceeds from (repayment of) short-term debt — 13

Payments of finance lease (4) —

Net cash provided by (used in) financing activities 105 (515)

Effect of exchange rate movements 2 10

Net increase (decrease) in cash, cash equivalents and restricted cash (31) 205

Cash, cash equivalents and restricted cash at beginning of period 1,791 1,332

Cash, cash equivalents and restricted cash at end of period $ 1,760 $ 1,537

Reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheets:

Cash and cash equivalents $ 1,758 $ 1,535

Restricted cash, included in other assets 2 2

Total cash, cash equivalents and restricted cash $ 1,760 $ 1,537

(a) Cash payments included in operating activities:

Income tax payments, net of refunds received $ 376 $ 304

Interest payments, net of capitalized interest $ 47 $ 55

Net change in property, plant and equipment included in accounts payable and accrued liabilities-increase (decrease) $ (9) $ —

Excise tax on share repurchases, accrued but not paid $ 2 $ 2

The preliminary cash flow is estimated based on our current information.

AGILENT TECHNOLOGIES, INC.

NON-GAAP NET INCOME AND DILUTED EPS RECONCILIATIONS

(In millions, except per share data)

(Unaudited)

PRELIMINARY

Three Months Ended Nine Months Ended

July 31, July 31,

2026 2025 2026 2025

Net Income Diluted

EPS Net Income Diluted

EPS

GAAP net income $ 362 $ 1.28

(b)

$ 336 $ 1.18 $ 1,006 $ 3.55

(c)

$ 869 $ 3.05

Non-GAAP adjustments:

Restructuring and other related costs 15 0.05 17 0.06 43 0.15 74 0.26

Asset impairments — — — — — — 15 0.05

Intangible amortization 21 0.07 26 0.09 59 0.21 81 0.28

Transformational initiatives 37 0.13 18 0.06 95 0.34 48 0.17

Acquisition and integration costs 7 0.02 3 0.01 22 0.08 15 0.05

Net (gain) loss on equity securities 5 0.02 1 — 6 0.02 28 0.10

Pension settlement loss — — — — — — 14 0.05

Other 8 0.03 12 0.05 42 0.15 27 0.09

Adjustment for taxes (a)

4 0.02 (23) (0.08) (5) (0.02) (31) (0.10)

Non-GAAP net income $ 459 $ 1.62

(b)

$ 390 $ 1.37 $ 1,268 $ 4.48

(c)

$ 1,140 $ 4.00

(a) The adjustment for taxes excludes tax expense (benefits) that management believes are not directly related to on-going operations and which are either isolated, temporary or cannot be expected to occur again with any regularity or predictability such as the realized gain/loss due to sale of a business, windfall benefits on stock compensation, and the impact of R&D capitalization under section 174 of the Tax Cuts and Jobs Act of 2017 which does not apply for fiscal year 2026 due to the enactment of the One Big Beautiful Bill Act (OBBBA). For the three and nine months ended July 31, 2026, management used a non-GAAP effective tax rate of 14.50%. For the three and nine months ended July 31, 2025, management used a non-GAAP effective tax rate of 12.00%.

(b) GAAP and Non-GAAP net income of $362 million and $459 million, respectively, includes a $17 million net benefit from tariff refunds. GAAP and Non-GAAP EPS of $1.28 and $1.62, respectively, includes a $0.06 net benefit from tariff refunds.

(c) GAAP and Non-GAAP net income of $1,006 million and $1,268 million, respectively, includes a $17 million net benefit from tariff refunds. GAAP and Non-GAAP EPS of $3.55 and $4.48, respectively, includes a $0.06 net benefit from tariff refunds.

We provide non-GAAP net income and non-GAAP net income per share amounts in order to provide meaningful supplemental information regarding our operational performance and our prospects for the future. These supplemental measures exclude, among other things, charges related to restructuring and other related costs, asset impairments, amortization of intangibles, transformational initiatives, acquisition and integration costs, net (gain) loss on equity securities and pension settlement loss.

Restructuring and other related costs include incremental expenses incurred in the period associated with restructuring programs, usually aimed at changes in business and/or cost structure. Such costs may include one-time termination benefits including acceleration of stock-based compensation expense, facility-related costs and contract termination fees.

Asset impairments include assets that have been written down to their fair value.

Intangible amortization refers to the systematic expensing of the cost of finite‑lived intangible assets over their estimated useful lives. Such assets, which include acquired patents, trademarks, customer lists, and other identifiable intangibles, are amortized to match the pattern in which their economic benefits are consumed. If the useful life is not reliably determinable, amortization is calculated on a straight‑line basis over the best estimate of that life.

Transformational initiatives include expenses associated with targeted cost reduction activities such as manufacturing transfers including costs to move manufacturing, site consolidations, legal entity and other business reorganizations, insourcing or outsourcing of activities. Such costs may include move and relocation costs, one-time termination benefits and other one-time reorganization costs. Included in this category are also expenses associated with company programs to transform our product lifecycle management (PLM) system and human resources and financial systems.

Acquisition and integration costs include all incremental expenses incurred to effect a business combination. Such acquisition costs may include advisory, legal, tax, accounting, valuation, and other professional or consulting fees. Such integration costs may include expenses directly related to integration of business and facility operations, the transfer of assets and intellectual property, information technology systems and infrastructure and other employee-related costs.

Net (gain) loss on equity securities relates to the realized and unrealized mark-to-market adjustments for our marketable and non-marketable equity securities.

Pension settlement loss resulted from the transfer of the Netherlands defined benefit plan to an unaffiliated insurance company.

Other includes certain legal costs and settlements, consulting costs, special compliance costs, acceleration of stock-based compensation expense and other miscellaneous adjustments.

Our management uses non-GAAP measures to evaluate the performance of our core businesses, to estimate future core performance and to compensate employees. Since management finds this measure to be useful, we believe that our investors benefit from seeing our results “through the eyes” of management in addition to seeing our GAAP results. This information facilitates our management’s internal comparisons to our historical operating results as well as to the operating results of our competitors.

Our management recognizes that items such as amortization of intangibles can have a material impact on our cash flows and/or our net income. Our GAAP financial statements including our statement of cash flows portray those effects. Although we believe it is useful for investors to see core performance free of special items, investors should understand that the excluded items are actual expenses that may impact the cash available to us for other uses. To gain a complete picture of all effects on the company’s profit and loss from any and all events, management does (and investors should) rely upon the GAAP income statement. The non-GAAP numbers focus instead upon the core business of the company, which is only a subset, albeit a critical one, of the company’s performance.

Readers are reminded that non-GAAP numbers are merely a supplement to, and not a replacement for, GAAP financial measures. They should be read in conjunction with the GAAP financial measures. It should be noted as well that our non-GAAP information may be different from the non-GAAP information provided by other companies.

The preliminary non-GAAP net income and diluted EPS reconciliation is estimated based on our current information.

AGILENT TECHNOLOGIES, INC.

RECONCILIATION OF NON-GAAP INCOME FROM OPERATIONS AND OPERATING MARGIN

(In millions, except margin data)

(Unaudited)

PRELIMINARY

Year Over Year

Operating Operating Percent Pts

Q3'26 Margin % Q3'25 Margin % Inc/(Dec)

GAAP revenue: $ 1,878 $ 1,738

Income from operations:

GAAP Income from operations $ 444 23.6 %

(a)

$ 360 20.7 %

Non-GAAP adjustments:

Restructuring and other related costs 15 17

Intangible amortization 21 26

Transformational initiatives 37 18

Acquisition and integration costs 7 3

Other 8 13

Non-GAAP income from operations $ 532 28.3 %

(a)

$ 437 25.1 % 3.2%

(a) GAAP and non-GAAP income from operations of $444 million and $532 million, respectively, includes a $20 million net benefit from tariff refunds. GAAP and non-GAAP operating margin of 23.6% and 28.3%, respectively, includes a 110 basis points net benefit from tariff refunds.

We provide non-GAAP income from operations and non-GAAP operating margin amounts in order to provide meaningful supplemental information regarding our operational performance and our prospects for the future. These supplemental measures exclude, among other things, charges related to restructuring and other related costs, amortization of intangibles, transformational initiatives and acquisition and integration costs.

The preliminary reconciliation of income from operations and operating margins is estimated based on our current information.

AGILENT TECHNOLOGIES, INC.

SEGMENT INFORMATION

(In millions, except where noted)

(Unaudited)

PRELIMINARY

Quarter-over-Quarter

Life Sciences and Diagnostics Markets Segment

Q3'26 Q3'25

Revenue $ 746 $ 670

Gross Margin, % 55.5 % 50.5 %

Income from Operations $ 176 $ 118

Operating margin, % 23.5 % 17.6 %

Agilent CrossLab Segment

Q3'26 Q3'25

Revenue $ 786 $ 744

Gross Margin, % 57.0 % 55.1 %

Income from Operations $ 270 $ 248

Operating margin, % 34.3 % 33.3 %

Applied Markets Segment

Q3'26 Q3'25

Revenue $ 346 $ 324

Gross Margin, % 57.3 % 53.6 %

Income from Operations $ 86 $ 71

Operating margin, % 24.9 % 21.8 %

Income from operations reflect the results of our reportable segments under Agilent's management reporting system which are not necessarily in conformity with GAAP financial measures. Income from operations of our reporting segments exclude, among other things, charges related to restructuring and other related costs, amortization of intangibles, transformational initiatives, acquisition and integration costs and net (gain) loss on equity securities.

The preliminary segment information is estimated based on our current information.

AGILENT TECHNOLOGIES, INC.

RECONCILIATIONS OF REVENUE BY SEGMENT

EXCLUDING ACQUISITIONS, DIVESTITURES AND THE IMPACT OF CURRENCY ADJUSTMENTS (CORE)

(In millions)

(Unaudited)

PRELIMINARY

Year-over-Year

GAAP

GAAP Revenue by Segment Q3'26 Q3'25 Year-over-Year

% Change

Life Sciences and Diagnostics Markets Segment $ 746 $ 670 11%

Agilent CrossLab Segment 786 744 6%

Applied Markets Segment 346 324 7%

Agilent $ 1,878 $ 1,738 8%

Non-GAAP

(excluding Acquisitions & Divestitures)

Year-over-Year at Constant Currency (a)

Non-GAAP Revenue by Segment Q3'26 Q3'25 Year-over-Year

% Change Year-over-Year % Change Percentage Point Impact from Currency

Current Quarter Currency Impact (b)

Life Sciences and Diagnostics Markets Segment $ 736 $ 670 10% 10% — $ 1

Agilent CrossLab Segment 786 744 6% 5% 1 ppt 2

Applied Markets Segment 346 324 7% 7% — 1

Agilent (Core) $ 1,868 $ 1,738 8% 7% 1 ppt $ 4

We compare the year-over-year change in revenue excluding the effect of recent acquisitions and divestitures and foreign currency rate fluctuations to assess the performance of our underlying business.

(a) The constant currency year-over-year growth percentage is calculated by recalculating all periods in the comparison period at the foreign currency exchange rates used for accounting during the last month of the current quarter and then using those revised values to calculate the year-over-year percentage change.

(b) The dollar impact from the current quarter currency impact is equal to the total year-over-year dollar change less the constant currency year-over-year change.

The preliminary reconciliation of GAAP revenue adjusted for recent acquisitions and divestitures and impact of currency is estimated based on our current information.

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 7

v3.26.1

Document and Entity Information Document

Aug. 26, 2026

Document and Entity Information [Abstract]

Entity Central Index Key

0001090872

Title of 12(b) Security

COMMON STOCK, $0.01 PAR VALUE

Entity Incorporation, State or Country Code

Document Type

8-K

Document Period End Date

Aug. 26, 2026

Entity Registrant Name

AGILENT TECHNOLOGIES, INC.

Entity Tax Identification Number

001-15405

Entity Tax Identification Number

77-0518772

Entity Address, Address Line One

5301 Stevens Creek Boulevard

Entity Address, City or Town

Santa Clara

Entity Address, State or Province

Entity Address, Postal Zip Code

95051

City Area Code

(800)

Local Phone Number

227-9770

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Entity Emerging Growth Company

false

Trading Symbol

Security Exchange Name

NYSE

Amendment Flag

false

- Definition

Document and Entity Information [Abstract]

+ References

No definition available.

+ Details

Name:

a_DocumentAndEntityInformationAbstract

Namespace Prefix:

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration